The treatment of AML is mainly chemotherapy and hematopoietic stem cell transplantation. 1. Acute myeloid leukemia is a malignant hematopoietic tumor of the blood system, which needs to receive chemotherapy in time, otherwise the disease progresses rapidly, and the survival period of the patients is short and easy to be life-threatening. Specific drugs include cytarabine and Zoerythromycin. 2. Hematopoietic stem cell transplantation is the fundamental treatment for curing acute myeloid leukemia, but not all patients need to undergo hematopoietic stem cell transplantation, only those with high risk stratification and at the same time younger than 55 years old need to undergo transplantation if there is a suitable donor. Complications after allogeneic HSCT are mainly graft-versus-host disease, severe infections, etc., which can be life-threatening if the condition worsens. Therefore, whether to undergo allogeneic HSCT needs to be consulted with a hematologist, and the choice should be made carefully according to the patient’s specific situation. All of the above medications should be used under the guidance of a physician.